US 9844598
Bacterially derived, intact minicells for delivery of therapeutic agents to brain tumors
granted A61KA61K47/46A61K47/6849
Quick answer
US patent 9844598 (Bacterially derived, intact minicells for delivery of therapeutic agents to brain tumors) held by EnGeneIC Molecular Delivery Pty Ltd expires Mon Dec 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- EnGeneIC Molecular Delivery Pty Ltd
- Grant date
- Tue Dec 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 32
- CPC classes
- A61K, A61K47/46, A61K47/6849, A61K51/1203, A61K9/5068